Eintrag weiter verarbeiten
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer
Gespeichert in:
| Zeitschriftentitel: | International Journal of Cancer |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , |
| In: | International Journal of Cancer, 111, 2004, 2, S. 303-309 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Bauerschmitz, Gerd J. Kanerva, Anna Wang, Minghui Herrmann, Isabell Shaw, Denise R. Strong, Theresa V. Desmond, Renee Rein, Daniel T. Dall, Peter Curiel, David T. Hemminki, Akseli Bauerschmitz, Gerd J. Kanerva, Anna Wang, Minghui Herrmann, Isabell Shaw, Denise R. Strong, Theresa V. Desmond, Renee Rein, Daniel T. Dall, Peter Curiel, David T. Hemminki, Akseli |
|---|---|
| author |
Bauerschmitz, Gerd J. Kanerva, Anna Wang, Minghui Herrmann, Isabell Shaw, Denise R. Strong, Theresa V. Desmond, Renee Rein, Daniel T. Dall, Peter Curiel, David T. Hemminki, Akseli |
| spellingShingle |
Bauerschmitz, Gerd J. Kanerva, Anna Wang, Minghui Herrmann, Isabell Shaw, Denise R. Strong, Theresa V. Desmond, Renee Rein, Daniel T. Dall, Peter Curiel, David T. Hemminki, Akseli International Journal of Cancer Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer Cancer Research Oncology |
| author_sort |
bauerschmitz, gerd j. |
| spelling |
Bauerschmitz, Gerd J. Kanerva, Anna Wang, Minghui Herrmann, Isabell Shaw, Denise R. Strong, Theresa V. Desmond, Renee Rein, Daniel T. Dall, Peter Curiel, David T. Hemminki, Akseli 0020-7136 1097-0215 Wiley Cancer Research Oncology http://dx.doi.org/10.1002/ijc.20217 <jats:title>Abstract</jats:title><jats:p>Treatment options for disseminated cervical cancer remain inadequate. Here, we investigated a strategy featuring Ad5‐Δ24RGD, an oncolytic adenovirus replication‐competent selectively in cells defective in the <jats:italic>Rb‐p16</jats:italic> pathway, such as most cervical cancer cells. The viral fiber contains an α<jats:sub>v</jats:sub>β<jats:sub>3</jats:sub> and α<jats:sub>v</jats:sub>β<jats:sub>5</jats:sub> integrin‐binding RGD‐4C motif, allowing coxsackie‐adenovirus receptor‐independent infection. These integrins have been reported to be frequently upregulated in cervical cancer. Oncolysis of cervical cancer cells was similar to a wild‐type control <jats:italic>in vitro</jats:italic>. In an animal model of cervical cancer, the therapeutic efficacy of Ad5‐Δ24RGD could be demonstrated for both intratumoral and intravenous application routes. Biodistribution was determined following intravenous administration to mice. Further preclinical safety data were obtained by demonstrating lack of replication of the agent in human peripheral blood mononuclear cells. These results suggest that Ad5‐Δ24RGD could be useful for local or systemic treatment of cervical cancer in patients with disease resistant to currently available modalities. © 2004 Wiley‐Liss, Inc.</jats:p> Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer International Journal of Cancer |
| doi_str_mv |
10.1002/ijc.20217 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMjAyMTc |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMjAyMTc |
| institution |
DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 |
| imprint |
Wiley, 2004 |
| imprint_str_mv |
Wiley, 2004 |
| issn |
0020-7136 1097-0215 |
| issn_str_mv |
0020-7136 1097-0215 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
bauerschmitz2004evaluationofaselectivelyoncolyticadenovirusforlocalandsystemictreatmentofcervicalcancer |
| publishDateSort |
2004 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
International Journal of Cancer |
| source_id |
49 |
| title |
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_unstemmed |
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_full |
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_fullStr |
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_full_unstemmed |
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_short |
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_sort |
evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1002/ijc.20217 |
| publishDate |
2004 |
| physical |
303-309 |
| description |
<jats:title>Abstract</jats:title><jats:p>Treatment options for disseminated cervical cancer remain inadequate. Here, we investigated a strategy featuring Ad5‐Δ24RGD, an oncolytic adenovirus replication‐competent selectively in cells defective in the <jats:italic>Rb‐p16</jats:italic> pathway, such as most cervical cancer cells. The viral fiber contains an α<jats:sub>v</jats:sub>β<jats:sub>3</jats:sub> and α<jats:sub>v</jats:sub>β<jats:sub>5</jats:sub> integrin‐binding RGD‐4C motif, allowing coxsackie‐adenovirus receptor‐independent infection. These integrins have been reported to be frequently upregulated in cervical cancer. Oncolysis of cervical cancer cells was similar to a wild‐type control <jats:italic>in vitro</jats:italic>. In an animal model of cervical cancer, the therapeutic efficacy of Ad5‐Δ24RGD could be demonstrated for both intratumoral and intravenous application routes. Biodistribution was determined following intravenous administration to mice. Further preclinical safety data were obtained by demonstrating lack of replication of the agent in human peripheral blood mononuclear cells. These results suggest that Ad5‐Δ24RGD could be useful for local or systemic treatment of cervical cancer in patients with disease resistant to currently available modalities. © 2004 Wiley‐Liss, Inc.</jats:p> |
| container_issue |
2 |
| container_start_page |
303 |
| container_title |
International Journal of Cancer |
| container_volume |
111 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792339348092354573 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:45:52.038Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Evaluation+of+a+selectively+oncolytic+adenovirus+for+local+and+systemic+treatment+of+cervical+cancer&rft.date=2004-08-20&genre=article&issn=1097-0215&volume=111&issue=2&spage=303&epage=309&pages=303-309&jtitle=International+Journal+of+Cancer&atitle=Evaluation+of+a+selectively+oncolytic+adenovirus+for+local+and+systemic+treatment+of+cervical+cancer&aulast=Hemminki&aufirst=Akseli&rft_id=info%3Adoi%2F10.1002%2Fijc.20217&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792339348092354573 |
| author | Bauerschmitz, Gerd J., Kanerva, Anna, Wang, Minghui, Herrmann, Isabell, Shaw, Denise R., Strong, Theresa V., Desmond, Renee, Rein, Daniel T., Dall, Peter, Curiel, David T., Hemminki, Akseli |
| author_facet | Bauerschmitz, Gerd J., Kanerva, Anna, Wang, Minghui, Herrmann, Isabell, Shaw, Denise R., Strong, Theresa V., Desmond, Renee, Rein, Daniel T., Dall, Peter, Curiel, David T., Hemminki, Akseli, Bauerschmitz, Gerd J., Kanerva, Anna, Wang, Minghui, Herrmann, Isabell, Shaw, Denise R., Strong, Theresa V., Desmond, Renee, Rein, Daniel T., Dall, Peter, Curiel, David T., Hemminki, Akseli |
| author_sort | bauerschmitz, gerd j. |
| container_issue | 2 |
| container_start_page | 303 |
| container_title | International Journal of Cancer |
| container_volume | 111 |
| description | <jats:title>Abstract</jats:title><jats:p>Treatment options for disseminated cervical cancer remain inadequate. Here, we investigated a strategy featuring Ad5‐Δ24RGD, an oncolytic adenovirus replication‐competent selectively in cells defective in the <jats:italic>Rb‐p16</jats:italic> pathway, such as most cervical cancer cells. The viral fiber contains an α<jats:sub>v</jats:sub>β<jats:sub>3</jats:sub> and α<jats:sub>v</jats:sub>β<jats:sub>5</jats:sub> integrin‐binding RGD‐4C motif, allowing coxsackie‐adenovirus receptor‐independent infection. These integrins have been reported to be frequently upregulated in cervical cancer. Oncolysis of cervical cancer cells was similar to a wild‐type control <jats:italic>in vitro</jats:italic>. In an animal model of cervical cancer, the therapeutic efficacy of Ad5‐Δ24RGD could be demonstrated for both intratumoral and intravenous application routes. Biodistribution was determined following intravenous administration to mice. Further preclinical safety data were obtained by demonstrating lack of replication of the agent in human peripheral blood mononuclear cells. These results suggest that Ad5‐Δ24RGD could be useful for local or systemic treatment of cervical cancer in patients with disease resistant to currently available modalities. © 2004 Wiley‐Liss, Inc.</jats:p> |
| doi_str_mv | 10.1002/ijc.20217 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMjAyMTc |
| imprint | Wiley, 2004 |
| imprint_str_mv | Wiley, 2004 |
| institution | DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275 |
| issn | 0020-7136, 1097-0215 |
| issn_str_mv | 0020-7136, 1097-0215 |
| language | English |
| last_indexed | 2024-03-01T15:45:52.038Z |
| match_str | bauerschmitz2004evaluationofaselectivelyoncolyticadenovirusforlocalandsystemictreatmentofcervicalcancer |
| mega_collection | Wiley (CrossRef) |
| physical | 303-309 |
| publishDate | 2004 |
| publishDateSort | 2004 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | International Journal of Cancer |
| source_id | 49 |
| spelling | Bauerschmitz, Gerd J. Kanerva, Anna Wang, Minghui Herrmann, Isabell Shaw, Denise R. Strong, Theresa V. Desmond, Renee Rein, Daniel T. Dall, Peter Curiel, David T. Hemminki, Akseli 0020-7136 1097-0215 Wiley Cancer Research Oncology http://dx.doi.org/10.1002/ijc.20217 <jats:title>Abstract</jats:title><jats:p>Treatment options for disseminated cervical cancer remain inadequate. Here, we investigated a strategy featuring Ad5‐Δ24RGD, an oncolytic adenovirus replication‐competent selectively in cells defective in the <jats:italic>Rb‐p16</jats:italic> pathway, such as most cervical cancer cells. The viral fiber contains an α<jats:sub>v</jats:sub>β<jats:sub>3</jats:sub> and α<jats:sub>v</jats:sub>β<jats:sub>5</jats:sub> integrin‐binding RGD‐4C motif, allowing coxsackie‐adenovirus receptor‐independent infection. These integrins have been reported to be frequently upregulated in cervical cancer. Oncolysis of cervical cancer cells was similar to a wild‐type control <jats:italic>in vitro</jats:italic>. In an animal model of cervical cancer, the therapeutic efficacy of Ad5‐Δ24RGD could be demonstrated for both intratumoral and intravenous application routes. Biodistribution was determined following intravenous administration to mice. Further preclinical safety data were obtained by demonstrating lack of replication of the agent in human peripheral blood mononuclear cells. These results suggest that Ad5‐Δ24RGD could be useful for local or systemic treatment of cervical cancer in patients with disease resistant to currently available modalities. © 2004 Wiley‐Liss, Inc.</jats:p> Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer International Journal of Cancer |
| spellingShingle | Bauerschmitz, Gerd J., Kanerva, Anna, Wang, Minghui, Herrmann, Isabell, Shaw, Denise R., Strong, Theresa V., Desmond, Renee, Rein, Daniel T., Dall, Peter, Curiel, David T., Hemminki, Akseli, International Journal of Cancer, Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer, Cancer Research, Oncology |
| title | Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_full | Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_fullStr | Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_full_unstemmed | Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_short | Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_sort | evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| title_unstemmed | Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1002/ijc.20217 |